Previous 10 | Next 10 |
Company Regains Compliance with NASDAQ Minimum Bid Requirement IRVINE, CA / ACCESSWIRE / December 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received formal n...
Gainers: MingZhu Logistics (YGMZ) +237%.Nxt-ID (NXTD) +99%.PainReform (PRFX) +39%.Takung Art (TKAT) +39%.Avenue Therapeutics (ATXI) +31%.Eloxx Pharmaceuticals (ELOX) +30%.Jupiter Wellness (JUPW) +29%.Vivos Therapeutics (VVOS) +25%.Cogent Biosciences (COGT) +24%.Marathon Patent ...
Gainers: Vivos Therapeutics (VVOS) +51%, Jupiter Wellness (JUPW) +21%, Evolus (EOLS) +27%, PainReform (PRFX) +24%, Rite Aid (RAD) +23%.Losers: BioCardia (BCDA) -23%, SCYNEXIS (SCYX) -19%, Zynerba Pharmaceuticals (ZYNE) -15%, Han...
Electrocardiograms Indicate Good Cardiac Function for Both Patients IRVINE, CA / ACCESSWIRE / December 16, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that two patients who have undergo...
Sio Gene Therapies (SIOX) +42% on positive AXO-AAV-GM1 data in nerve cell disorder.Good Times Restaurants (GTIM) +27% on Q4 results.Tilray (TLRY) +27% as company to combine with Aphria to create largest global cannabis company.DAVIDsTEA (DTEA) +25% on Q3 results.NeuBa...
Patients Show Significant Improvements in Reflux, VCSS, and VAS Scores IRVINE, CA / ACCESSWIRE / December 15, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the final ag...
Gainers: Anchiano Therapeutics ANCN +173%, Prevail Therapeutics PRVL +84%, BioCardia (BCDA) +40%, Solid Biosciences (SLDB) +37%, OncoCyte OCX +32%.Losers: Mirum Pharmaceuticals (MIRM) -21%, Mesoblast (MESO) -18%, Rubius Therapeutics ...
Final Patient in First-in-Human Study Shows Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / December 14 , 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today tha...
Gainers: Sonoma Pharmaceuticals (SNOA) +87%.aTyr Pharma (LIFE) +65%.NantHealth (NH) +63%.vTv Therapeutics (VTVT) +55%.Equus Total Return (EQS) +45%Hancock Jaffe Laboratories (HJLI) +34%.MDJM (MDJH) +25%.Foresight Autonomous (FRSX) +23%.Solid Biosciences (SLDB) +22%.22...
VenoValve and CoreoGraft Primary Investigators to Present at Webinar IRVINE, CA / ACCESSWIRE / December 10 , 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that on Wednesday, December 1...
News, Short Squeeze, Breakout and More Instantly...
Hancock Jaffe Laboratories Inc. Company Name:
HJLI Stock Symbol:
NASDAQ Market:
Company Now Trading Under Ticker Symbol "NVNO" IRVINE, CA / ACCESSWIRE / October 1, 2021 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully comple...
Live webinar followed by Q&A on Monday, September 27 th at 1:00 PM ET with Robert Berman Chief Executive Officer of Hancock Jaffe Laboratories IRVINE, CA / ACCESSWIRE / September 24, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a medic...
- Hancock Jaffe changing name to enVVeno Medical Corporation and ticker symbol to NASDAQ: NVNO, effective October 1, 2021 - - Development strategy to focus on venous disease and advancement of the VenoValve® - - Initiated development of second product for the treatment of veno...